Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Anbio Biotechnology NNNN

Set alert

Price alert · NNNN

All alert types
3.51 USD +0.15 +4.46%

At close · Nov 2

3.43 -0.08 -2.25%

After hours · Nov 2, 4:04 PM ET

Bid
3.49 × 1
Ask
3.57 × 1
3.42 Day range 3.73
3.09 52-week range 44.73
YTD
-88.33%
1 year
-79.17%
Open
3.42
Prev close
3.36
Mkt cap
154.06M
Vol
56.46K
Avg vol
151.59K
EPS
0.15
P/E
23.40
Div yield
0.00%
More statistics
Low
3.42
High
3.73
Forward P/E
0.00
Beta
0.00
Short ratio
1.79
Inst. own
4.90%
Dividend
0.00
Ex-div date
50-d avg
22.29
200-d avg
25.98
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for NNNN has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

1010.98 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 2
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E 188×
FY 2021: 227×FY 2022: 82.9×FY 2023: 368×FY 2024: 103×FY 2025: 188×
FY 2021 5y median 188× FY 2025
P/S 153×
FY 2021: 130×FY 2022: 35.3×FY 2023: 124×FY 2024: 29.8×FY 2025: 153×
FY 2021 5y median 124× FY 2025
P/B 43.8×
FY 2021: 228×FY 2022: 66.2×FY 2023: 56.0×FY 2024: 14.2×FY 2025: 43.8×
FY 2021 5y median 56.0× FY 2025
P/FCF -196×
FY 2021: 138×FY 2022: 187×FY 2023: 924×FY 2024: 117×FY 2025: -196×
FY 2021 5y median 138× FY 2025
EV/EBITDA 227×
FY 2021: 226×FY 2022: 82.1×FY 2023: 362×FY 2024: 116×FY 2025: 227×
FY 2021 5y median 226× FY 2025
EV/Sales 152×
FY 2021: 129×FY 2022: 35.0×FY 2023: 122×FY 2024: 28.4×FY 2025: 152×
FY 2021 5y median 122× FY 2025
FCF Yield -0.5%
FY 2021: 0.7%FY 2022: 0.5%FY 2023: 0.1%FY 2024: 0.9%FY 2025: -0.5%
FY 2021 5y median 0.5% FY 2025

Profitability

Gross Margin 87.2%
FY 2021: 57.4%FY 2022: 53.4%FY 2023: 50.1%FY 2024: 71.9%FY 2025: 87.2%
FY 2021 5y median 57.4% FY 2025
Operating Margin 66.7%
FY 2021: 55.5%FY 2022: 43.3%FY 2023: 29.2%FY 2024: 24.4%FY 2025: 66.7%
FY 2021 5y median 43.3% FY 2025
Net Margin 74.1%
FY 2021: 57.3%FY 2022: 42.5%FY 2023: 33.6%FY 2024: 29.0%FY 2025: 74.1%
FY 2021 5y median 42.5% FY 2025
ROE 21.2%
FY 2021: 100.0%FY 2022: 79.8%FY 2023: 15.2%FY 2024: 13.8%FY 2025: 21.2%
FY 2021 5y median 21.2% FY 2025
ROIC 19.1%
FY 2021: 96.8%FY 2022: 81.3%FY 2023: 13.2%FY 2024: 11.6%FY 2025: 19.1%
FY 2021 5y median 19.1% FY 2025
ROA 21.2%
FY 2021: 51.6%FY 2022: 71.7%FY 2023: 14.3%FY 2024: 12.5%FY 2025: 21.2%
FY 2021 5y median 21.2% FY 2025

Growth (YoY)

Revenue 5.6%
FY 2021: 0.0%FY 2022: 431.7%FY 2023: -71.5%FY 2024: 21.9%FY 2025: 5.6%
FY 2021 FY 2025
Operating Income 189.1%
FY 2021: 0.0%FY 2022: 315.2%FY 2023: -80.8%FY 2024: 1.8%FY 2025: 189.1%
FY 2021 FY 2025
EPS (diluted) 185.7%
FY 2021: 0.0%FY 2022: 174.0%FY 2023: -82.8%FY 2024: 366.7%FY 2025: 185.7%
FY 2021 FY 2025
Free Cash Flow -423.9%
FY 2021: 0.0%FY 2022: 6.4%FY 2023: -79.8%FY 2024: 131.6%FY 2025: -423.9%
FY 2021 FY 2025

Financial Health

Current Ratio 344×
FY 2021: 2.1×FY 2022: 9.9×FY 2023: 15.9×FY 2024: 10.7×FY 2025: 344×
FY 2021 5y median 10.7× FY 2025
Quick Ratio 344×
FY 2021: 2.1×FY 2022: 9.6×FY 2023: 15.9×FY 2024: 10.7×FY 2025: 344×
FY 2021 5y median 10.7× FY 2025
Debt / Equity 0.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA -1.3×
FY 2021: -1.6×FY 2022: -0.7×FY 2023: -4.3×FY 2024: -5.9×FY 2025: -1.3×
FY 2021 5y median -1.6× FY 2025
Interest Coverage 0.0×
FY 2021: 0.0×FY 2022: 1275×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31